Cardiff, UK – 17th July 2012 – Stanbio Laboratory, an EKF Diagnostics company, has developed the ß-Hydroxybutyrate LiquiColor® Reagent System to improve the detection of clinically significant ketosis.
Ketosis is elevated levels of ketones in the body that occur when stored fats are broken down in response to a low supply of energy (glucose). Using the reagent system, levels of the ketone ß-Hydroxybutyrate in serum and plasma can be used to clinically diagnose and monitor diabetes mellitus, alcoholism, glycogen storage disease, high fat/low carbohydrate diets, pregnancy, alkalosis, ingestion of isopropyl alcohol, and salicylate poisoning.
As ß-Hydroxybutyrate is the main ketone produced during ketosis (~78%), the blood assay provides a better tool than the nitroprusside test strips commonly used for the detection of ketone bodies in urine, which only detect 22% of ketones present. ß-Hydroxybutyrate also demonstrates excellent stability, making it the most reliable indicator of clinically relevant ketosis and ketoacidosis.
Stanbio Laboratory’s ß-Hydroxybutyrate LiquiColor® Reagent System produces quantitative and objective results and provides an excellent tool for differentiating metabolic acidosis and monitoring therapy. Its precise and sensitive quantitative results enable earlier detection of ketosis and faster patient treatment, thus improving Emergency Room (ER) and Critical Decision Unit (CDU) throughput and efficiency.
To find out more about Stanbio Laboratory’s ß-Hydroxybutyrate LiquiColor® Reagent System please visit http://www.stanbio.com/
About EKF Diagnostics Holdings plc
The EKF Diagnostics Group has expertise across the entire in vitro diagnostics chain, from fermentation and enzyme production, to the manufacture of liquid reagents, the design and building of world-class diagnostic devices and the distribution of rapid test kits for infectious diseases and pregnancy. The EKF range of analysers are a trusted brand in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for the measurement of glucose, lactate, haemoglobin, haematocrit and HbA1c.
To date, the EKF Diagnostics Group has distributors in more than 70 locations around the globe. EKF Diagnostics’ strengths lie in its multi-national research and manufacturing facilities, teams of experienced analysts and engineers in Germany, Ireland, USA and the UK, and a board led by some of world’s foremost authorities in medical diagnostics.